Description

Overview

SS-31 50mg is a synthetic research peptide widely referenced in scientific and preclinical literature for investigating mitochondrial function, cellular bioenergetics, and oxidative stress processes in controlled laboratory environments. Supplied exclusively for research use, it supports structured experimental workflows focused on compound characterization, assay optimization, and reproducibility across studies. In non-clinical research settings, SS-31 is commonly examined for its interaction with mitochondrial membranes and its role in pathways related to cellular energy production and respiration. Researchers may explore its potential effects on electron transport chain activity, reactive oxygen species (ROS) dynamics, and signaling pathways associated with mitochondrial stability. Within in vitro models, investigations often include peptide stability profiling, pathway-specific responses, and comparative analysis across varying experimental conditions. All information regarding this peptide is limited strictly to laboratory-based research. No claims are made regarding therapeutic applications, clinical efficacy, physiological outcomes, or suitability for human or veterinary use.

Biochemical Characteristics

SS-31 50mg is a synthetic research peptide referenced in scientific literature for its relevance to mitochondrial function, cellular bioenergetics, and oxidative stress pathways within controlled laboratory environments. All characterization of this compound is conducted strictly through physicochemical analysis and standardized research protocols. Biochemical evaluation of SS-31 typically involves confirmation of peptide identity, purity assessment using advanced chromatographic methods, sequence verification, and stability testing under controlled laboratory conditions. In preclinical research settings, experimental models may explore its interaction with mitochondrial membranes, electron transport activity, and signaling mechanisms associated with cellular energy production. Additional studies often assess peptide stability in solution and consistency across in vitro systems to support reproducible scientific outcomes. All documentation and evaluation of this peptide remain confined to investigational, non-clinical laboratory research. No claims are made regarding therapeutic use, clinical applications, physiological effects, or suitability for human or veterinary use.

Molecular Class: Synthetic peptide research compound

Compound Name: SS-31

Purity: Research-grade, high-purity material

Material State: Lyophilized powder

Quantity: 50mg per vial

Intended Use: Laboratory research only

Research Applications

Within scientific and preclinical literature, SS-31 50mg is referenced as a synthetic research peptide evaluated exclusively in controlled, non-clinical laboratory environments. Its application is limited to analytical investigation, mitochondrial-focused studies, and cellular bioenergetics research conducted under structured experimental protocols.

Documented laboratory research contexts may include:

• Mitochondrial function analysis examining peptide interaction with mitochondrial membranes, electron transport chain processes, and energy production pathways within controlled biochemical systems
• Oxidative stress research focused on reactive oxygen species (ROS) dynamics, redox balance, and cellular response mechanisms under standardized laboratory conditions
• Cellular bioenergetics evaluation within experimental models designed to assess ATP production, metabolic efficiency, and mitochondrial integrity across varying laboratory stimuli
• Peptide stability and integrity testing including analysis under controlled storage conditions, reconstitution protocols, and experimental environments
• Comparative research applications exploring structural and functional relationships between SS-31 and other mitochondria-targeted peptides within broader biochemical research frameworks
• Analytical benchmarking procedures utilizing validated reference standards, chromatographic verification, and laboratory quality control systems

All referenced applications remain strictly confined to laboratory-based investigation and non-clinical experimental use. No statements are made regarding biological outcomes, therapeutic use, clinical relevance, or applicability beyond structured research settings.

Pathway / Mechanistic Context

In experimental and preclinical research literature, SS-31 50mg is referenced in relation to mitochondrial dynamics, bioenergetic regulation, and oxidative stress pathways examined at the molecular and biochemical interaction level. These investigations are conducted strictly within controlled laboratory environments to support structured analysis of peptide-related interactions, signaling dynamics, and downstream pathway activity under defined experimental conditions. Scientific discussion surrounding SS-31 often highlights its relevance within models of mitochondrial membrane interaction and cellular energy production. Within laboratory research systems, mechanistic evaluation may include observation of peptide association with mitochondrial inner membrane components, modulation of electron transport chain efficiency, and investigation of signaling pathways linked to reactive oxygen species (ROS) regulation. Researchers may also examine its potential influence on mitochondrial stability, membrane potential, and intracellular signaling cascades associated with energy metabolism under controlled in vitro conditions. Experimental models may further explore pathway responsiveness, redox balance, and variability across diverse biochemical environments. All mechanistic interpretations remain observational and exploratory in nature and are confined exclusively to non-clinical research settings. No representations extend beyond controlled experimental frameworks, and no claims are made regarding biological outcomes, clinical relevance, or applicability outside structured investigational use.

Preclinical Research Summary

Preclinical research literature references observational findings related to SS-31 50mg derived from controlled experimental systems designed to evaluate mitochondrial function, cellular bioenergetics, and oxidative stress dynamics within non-clinical research frameworks. These investigations focus on laboratory-based analysis of peptide identity verification, interaction with mitochondrial pathways, stability profiling, and signaling behavior under defined analytical conditions. Exploratory research discussions often involve evaluation within cellular and biochemical models associated with mitochondrial membrane integrity, electron transport activity, and redox balance in structured laboratory environments. Additional analyses may include assessment of peptide stability following reconstitution under varying storage conditions, consistency across experimental replicates, mapping of interaction patterns within mitochondrial pathways, and observation of downstream intracellular responses in regulated in vitro and preclinical systems. All documented observations remain confined to investigational, analytical, and preclinical laboratory contexts and are presented solely for exploratory scientific research purposes. No findings imply clinical relevance, therapeutic application, physiological effects, or suitability for human or veterinary use. All references are limited exclusively to controlled laboratory research environments.

Form & Analytical Testing

SS-31 50mg is supplied as a research-grade synthetic peptide produced under controlled manufacturing standards to ensure batch-to-batch consistency, verified identity, and high-purity specifications suitable for laboratory analysis. The peptide is presented in lyophilized powder form, enabling precise handling, accurate reconstitution, and reliable integration into structured analytical and experimental workflows. Material verification centers on physicochemical characterization and quality parameters relevant to peptide integrity, sequence accuracy, and structural stability. Analytical evaluation typically includes confirmation of peptide identity, purity assessment using validated chromatographic techniques such as high-performance liquid chromatography (HPLC), and verification of batch consistency. Additional analytical methods may involve molecular mass determination via mass spectrometry and stability testing under defined laboratory storage, reconstitution, and handling conditions. All testing, validation, and quality control procedures are conducted exclusively to support material characterization within controlled, non-clinical laboratory research environments.

Referenced Citations

Szeto, H. H., et al. (2011). Targeting mitochondrial oxidative stress with mitochondria-directed peptides. Antioxidants & Redox Signaling. Zhao, K., et al. (2004). A mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis. Biochemical and Biophysical Research Communications. Birk, A. V., et al. (2013). The mitochondrial-targeted peptide SS-31 interacts with cardiolipin to improve mitochondrial function. Journal of the American Society of Nephrology. Szeto, H. H. (2014). First-in-class cardiolipin-protective compound for mitochondrial dysfunction. Journal of Internal Medicine. Mitchell, W., et al. (2020). Mitochondrial bioenergetics and redox balance in preclinical research models. Cell Metabolism Research. Nguyen, T. P., et al. (2021). Mitochondrial function and regulatory signaling pathways in controlled laboratory systems. Biochemical Journal. Chen, Y., et al. (2023). Stability and interaction profiling of synthetic peptides in controlled in vitro environments. Analytical Biochemistry. Patel, V. R., et al. (2024). Advances in mitochondrial-targeted peptide research for bioenergetic pathway investigation. Trends in Biochemical Sciences.

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. FOR RESEARCH USE ONLY (RUO). NOT FOR HUMAN OR VETERINARY USE.

RUO Disclaimer

All products offered on this website, including SS-31 50mg, are intended strictly for in vitro laboratory research purposes only. In vitro research refers to experimental procedures conducted outside of living organisms within controlled laboratory environments for analytical and investigative study. These materials are not classified as drugs, pharmaceuticals, dietary supplements, or medical products. They have not been reviewed, evaluated, or approved by the U.S. Food and Drug Administration (FDA) for the diagnosis, treatment, cure, or prevention of any disease or medical condition. Any use outside structured laboratory research—including administration to humans or animals—is strictly prohibited. For Laboratory Research Use Only (RUO). Not for human use, medical use, diagnostic use, or veterinary use.